Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Bagby, Stacey M, Dominguez, Adrian T A, Dus, Evan D, Binns, Cameron A, MacBeth, Morgan, Whitty, Phaedra A, Diamond, Jennifer R, Pitts, Todd M
Published in Breast cancer research : BCR (01.03.2024)
Published in Breast cancer research : BCR (01.03.2024)
Get full text
Journal Article
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
Davis, S Lindsey, Messersmith, Wells A, Purcell, W Thomas, Lam, Elaine T, Corr, Bradley R, Leal, Alexis D, Lieu, Christopher H, O'Bryant, Cindy L, Smoots, Stephen G, Dus, Evan D, Jordan, Kimberly R, Serkova, Natalie J, Pitts, Todd M, Diamond, Jennifer R
Published in Cancers (10.04.2024)
Published in Cancers (10.04.2024)
Get full text
Journal Article
Abstract LB_C06: Utilizing a novel HDAC inhibitor bocodepsin (OKI-179) to overcome doxorubicin resistance in triple-negative breast cancer
Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Dus, Evan D, Bagby, Stacey M, Dominguez, Adrian T A., Binns, Cameron A, Diamond, Jennifer R, Pitts, Todd M
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract LB_C07: Utilizing a BCL-2 inhibitor (venetoclax) to overcome doxorubicin resistance in triple-negative breast cancer
Dus, Evan D, Smoots, Stephen G, Schreiber, Anna R, Jackson, Marilyn M, Bagby, Stacey M, Dominguez, Adrian T A, Binns, Cameron A, Pitts, Todd M, Diamond, Jennifer R
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article